The identity section of a peptide certificate of analysis almost always reduces to one comparison: an observed mass-to-charge ratio (m/z), measured on the instrument, against a theoretical mass calculated from the sequence. If the observed value lands within the instrument's stated tolerance of the theoretical value, identity is confirmed. Everything else on that line, the charge state, any adduct label, monoisotopic versus average mass, exists to explain why the raw printed number is not simply the peptide's molecular weight.
| Parameter | Typical value | Source |
|---|---|---|
| What a COA identity line compares | Observed m/z (instrument) vs theoretical mass (from sequence) | Ho et al., 2003 |
| ESI ion type for peptides | Multiply protonated [M+zH]^z+, not a single M+H peak | Fenn et al., 1989 |
| Quadrupole mass accuracy (typical) | Unit resolution, roughly 0.1-0.5 Da absolute | Hu et al., 2005 |
| TOF mass accuracy (typical) | Roughly 5-20 ppm externally calibrated | Hu et al., 2005 |
| Orbitrap mass accuracy (typical) | Roughly 1-5 ppm | Hu et al., 2005 |
| Sodium adduct shift, [M+Na]+ vs [M+H]+ | +21.98 Da | Ho et al., 2003 |
| Methionine oxidation shift | +15.99 Da (commonly rounded to +16) | Liu et al., 2013 |
| Deamidation shift (Asn/Gln) | +0.98 Da (commonly rounded to +1) | Yang and Zubarev, 2010 |
What is the difference between observed and theoretical mass on a COA?
Theoretical mass is arithmetic: sum the residue masses predicted by the sequence, add one water molecule for the terminal groups, and that total is the expected molecular weight. Observed mass is whatever the instrument actually recorded for that lot, converted from the raw m/z signal back to a neutral mass using the assigned charge state. A COA passes identity when the two numbers agree inside a stated tolerance, expressed in parts per million (ppm) on high-resolution instruments or in daltons on lower-resolution ones. For the arithmetic behind the theoretical side, see how to calculate a peptide's molecular weight and formula from its sequence.
Monoisotopic vs average mass: which one should match?
A peptide formula contains carbon, hydrogen, nitrogen, oxygen and sometimes sulfur, and every one of those elements has more than one naturally occurring isotope. Monoisotopic mass uses only the most abundant isotope of each element (carbon-12, hydrogen-1, nitrogen-14, oxygen-16, sulfur-32) and is the sharpest number to calculate and match against a high-resolution instrument's most intense isotope peak. Average mass is a weighted mean across the natural isotope distribution of every atom, and it is what a lower-resolution instrument reports when it sees one broad, unresolved envelope rather than individual isotope peaks. The gap between the two widens with peptide size; a short peptide under roughly 1,500 Da shows a difference well under 1 Da, while a peptide the size of a GLP-1 analog can show a gap of 2-3 Da. A careful COA states which convention it used rather than leaving the reader to guess.
Why does electrospray ionization produce more than one peak for a single peptide?
Electrospray ionization (ESI), the method behind most LC-MS identity testing, does not simply knock one electron off a molecule. It adds protons to basic sites along the backbone and side chains, producing a family of ions that each carry a different number of added protons (Fenn et al., 1989). Each ion is written [M+zH]^z+, where M is the neutral peptide mass, z is the number of protons added, and:
m/z = (M + z × 1.00728) / z
The 1.00728 is the mass of a proton, not a full hydrogen atom (which also carries an electron). A peptide with several basic residues, lysine, arginine, histidine, or a free amine terminus, ionizes across several charge states at once, so a spectrum often shows two, three or four peaks for one compound. The software works backward from whichever peak it is told to use, multiplying m/z by z and subtracting the proton mass, to arrive at the single neutral mass printed on the certificate (Ho et al., 2003).
Worked example: BPC-157 across charge states 1 through 4
BPC-157 is a 15-residue peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with an average molecular weight of approximately 1419.53 Da. Applying the formula above at each charge state gives the values expected across a spectrum of this peptide:
| Charge state (z) | Ion | Calculated m/z | Isotope peak spacing |
|---|---|---|---|
| 1 | [M+H]+ | 1420.54 | ~1.00 Da |
| 2 | [M+2H]2+ | 710.77 | ~0.50 Da |
| 3 | [M+3H]3+ | 474.18 | ~0.33 Da |
| 4 | [M+4H]4+ | 355.89 | ~0.25 Da |
The spacing between isotope peaks within a single charge-state envelope shrinks as z increases, because that spacing equals roughly one neutron mass divided by the charge (1.003 / z). This is the most useful visual cue for reading a raw spectrum: count the gap between adjacent isotope peaks in daltons, take its reciprocal, and that is the charge state, independent of whatever the software reports. Lot-specific identity data for this peptide is posted on our BPC-157 product page.
What do sodium, potassium and TFA adducts do to the spectrum?
Peptides rarely ionize in complete isolation. Trace sodium and potassium, present in nearly every buffer, glass vial and even lab water, displace a proton on a fraction of the molecules, producing [M+Na]+ and [M+K]+ ions alongside the expected [M+H]+ peak. Because sodium (22.99 Da) and potassium (39.10 Da) are heavier than the proton they replace, these adducts appear as satellite peaks roughly 22 Da and 38 Da above the protonated peak, not as a shift in the main identity peak. A spectrum dominated by sodium or potassium adducts usually signals a sample-handling issue, such as residual salt from synthesis or purification, rather than a problem with identity. Trifluoroacetic acid (TFA), the counterion most research peptides carry after reversed-phase purification, behaves differently: it tends to ion-pair with the peptide in the mobile phase rather than form a stable mass-shifted adduct in positive mode, which can suppress ionization efficiency and broaden peaks if TFA concentration is not controlled (García, 2005). For why a peptide arrives as a TFA salt, and how that relates to oxidation and deamidation, see how peptides degrade.
What do water loss, oxidation and deamidation look like on a spectrum?
Several common chemical changes shift mass by a small, predictable amount, often enough to identify which one occurred.
Water loss
A peak 18.01 Da lighter than expected, [M-H2O+H]+, usually reflects an in-source or in-solution dehydration, commonly from a glutamine or serine side chain, rather than a change to the bulk material.
Oxidation
Methionine, and to a lesser extent tryptophan and histidine, can pick up an oxygen atom, adding 15.99 Da (commonly described as a +16 shift). This shows up as a second, smaller peak roughly 16 Da above the main peak, since oxidation typically affects only a fraction of the molecules in a lot (Liu et al., 2013).
Deamidation
Asparagine and glutamine side chains can hydrolyze to aspartate and glutamate, adding 0.98 Da, which rounds to +1 Da on a lower-resolution instrument. This is easily confused with a simple isotope-counting error, which is why a +1 Da discrepancy deserves a second look rather than automatic dismissal (Yang and Zubarev, 2010).
Adduct and modification delta reference table
| Species | Mass shift from [M+H]+ | What it usually indicates |
|---|---|---|
| Sodium adduct [M+Na]+ | +21.98 Da | Trace sodium in buffer, glass or water |
| Potassium adduct [M+K]+ | +37.96 Da | Trace potassium, same sources as sodium |
| Water loss [M-H2O+H]+ | -18.01 Da | In-source dehydration, often Gln or Ser |
| Oxidation (Met, Trp, His) | +15.99 Da (~+16) | Partial oxidation of a susceptible residue |
| Deamidation (Asn, Gln) | +0.98 Da (~+1) | Hydrolysis of the amide side chain |
| Dimer [2M+zH]^z+ | mass of the ion is roughly double the monomer's mass | Gas-phase or solution-phase self-association, not a synthesis error by itself |
What does a doubled mass or a mass off by exactly 1 Da usually mean?
A peak at roughly twice the expected neutral mass is almost always a dimer, two copies of the peptide associating in solution or transiently in the gas phase, rather than a different, larger contaminant (Gururaja et al., 2007). Dimer peaks are common for peptides with complementary charged or hydrophobic residues and do not by themselves indicate a failed synthesis; confirm by checking the dimer peak's charge-state series and isotope spacing against twice the monomer mass. A mass off by exactly 1 Da is the classic signature of deamidation, but it can also reflect a software error in monoisotopic peak picking on a noisy spectrum. Distinguishing the two requires the whole isotope envelope, not a single reported number.
How tight should the match be, and does the analyzer matter?
Tolerance depends on the mass analyzer generating the number, and a COA that reports one without naming the instrument gives less information than it should. Quadrupole and ion-trap systems operate at unit mass resolution, distinguishing peaks about 1 Da apart but not finer, so a reasonable identity tolerance there is 0.1-0.5 Da absolute. Time-of-flight (TOF) analyzers resolve more finely, usually 5-20 ppm with external calibration; for a 1,400 Da peptide that is roughly 0.007-0.03 Da. Orbitrap and FT-ICR instruments push further, often to 1-5 ppm, since they measure ion oscillation frequency rather than time-of-flight or deflection (Hu et al., 2005). A tolerance tighter than roughly 5 ppm without naming an Orbitrap, FT-ICR, or equivalent high-resolution instrument is worth asking about directly.
Frequently asked questions
Why does a peptide COA list a charge state instead of just the molecular weight?
Because the mass spectrometer measures mass-to-charge ratio, not mass directly. The charge state is how many protons were added for that particular peak, the conversion factor needed to get back to the neutral mass that matches the theoretical calculation.
Is a small shoulder peak next to the main identity peak a problem?
Not automatically. Sodium and potassium adducts, partial oxidation, and trace dimer are common, low-abundance companions to the main peak in an otherwise clean spectrum. What matters is the relative intensity of the main peak and whether stated purity already accounts for these minor species.
What is the practical difference between a quadrupole, a TOF and an Orbitrap for this check?
A quadrupole confirms mass within a few tenths of a dalton, enough to rule out a grossly wrong peptide but not to catch a single amino acid substitution on a large peptide. A TOF or Orbitrap resolves mass to a few ppm, tight enough to distinguish a deamidated or oxidized form from the parent by mass shift alone (Hu et al., 2005).
Can two different peptides share the same nominal mass and be confused on a low-resolution instrument?
Yes, particularly isobaric sequences that differ only by a swap like leucine for isoleucine, identical in mass. Mass spectrometry alone cannot distinguish them; that needs a complementary method such as amino acid analysis or tandem MS fragmentation.
Why do some COAs report monoisotopic mass and others report average mass for the same peptide?
It reflects instrument resolution and the convention of the reference standard the lab calibrates against. High-resolution instruments that resolve individual isotope peaks naturally report monoisotopic mass; lower-resolution instruments that see one broad envelope report an average mass, since that is what the envelope's centroid represents.
If the observed mass is within tolerance, does that confirm purity as well as identity?
No. A mass match confirms the dominant species detected has the expected weight; it says nothing about how much of the sample is that species relative to related impurities, a separate measurement typically made by HPLC. See HPLC vs LC-MS vs MALDI-TOF for peptide identity for how the two fit together on a full certificate.
References
- Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. PubMed 2675315.
- Ho CS, Lam CW, Chan MH, et al. Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev. 2003;24(1):3-12. PubMed 18568044.
- Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Cooks RG. The Orbitrap: a new mass spectrometer. J Mass Spectrom. 2005;40(4):430-43. PubMed 15838939.
- Yang H, Zubarev RA. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides. Electrophoresis. 2010;31(11):1764-72. PubMed 20446295.
- Liu H, Ponniah G, Neill A, et al. Accurate determination of protein methionine oxidation by stable isotope labeling and LC-MS analysis. Anal Chem. 2013;85(24):11705-9. PubMed 24200102.
- García MC. The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;825(2):111-23. PubMed 16213445.
- Gururaja TL, Narasimhamurthy S, Payan DG, Anderson DC. Gas phase dimerization of neuropeptide head activator analogs useful for the noncovalent constraint of peptides. Biopolymers. 2007;88(1):55-63. PubMed 17091497.
Research use only. Homegrown Peptides products are for laboratory research and are not for human or animal use. Nothing in this article is medical advice.
